Do-Coop Drug Delivery Systems, Drug Development for the Pharma Industry
October 20, 2006: Do-Coop Technologies, presented Neowater at the Israel Nanotechnology annual NFM (Nano Functional Materials) Meeting

 

 
Eran Gabbai, Founder, President and CTO of Do-Coop Technologies, presented Neowater at the Israel Nanotechnology annual NFM (Nano Functional Materials) Meeting, October 18, 2006, in Carmiel, Israel.
 About Us   |    Neowater   |    Technology   |    Pharma   |    Biotech   |    Pharma Overview   |    Business   |    Posters / Presentations   |    Media Center   |    Business Opportunities   |    Recent Collaborations   |    Biotech Overview   |    Understanding Water   |    Video Gallery   |    Do-Coop IP / Patents   |    Company Overview   |    Advisory Board   |    Management   |    News & PR   |    Pharma Applications   |    Business Contact   |    Publications   |    Articles   |    Biotech Applications   |   Contact us   |   Drug Articles

All rights reserved to Do-Coop Technologies Ltd which developed a novel drug delivery system that offers a revolutionary solution for Drug development challenges. Do-Coop's proprietary water based nanotechnology which is branded as NeowaterŪ offers an added value to Hydrophobic compounds, drug stability, drug bioavailability, small molecule solubilization, drug efficacy, Antibody stabilization, Protein stabilization, Enzyme stabilization, Stem cell viability, Stem cell growth, Cell line viability, transfection, , Stem cells media and Cell line cryopreservation. With Do-Coop Technologies the formulation of drugs is a fast, high quality and time saving process. | Drug development RSS Feed

Encountered with a broken link or other Website malfunction? Please contact the Site Administrator
This site is best viewed on Internet explorer version 5.5 or higher